It was a pleasure to meet Sergio Sandrucci, Professor of Surgery, University of Turin, at the ECCO 2019 European Cancer Summit in Brussels to discuss specialisation in the cancer workforce and whether it helps improve outcomes for patients and health systems.
1. What factors are driving moves towards specialisation in cancer care? (0:10)
2. Does specialisation in cancer care lead to improved quality of cancer care and better outcomes – what evidence is there to support this? (0:47)
3. Do all patients have access to the appropriate specialist care? Could remoteness of specialist treatment centres or their scarcity deter or prevent many from visiting them? (1:38)
4. Should specialist care be given throughout the disease course, or can continuing care be handed to general physicians when treatment is initiated? (2:12)
5. Is the movement toward specialist care at centralised treatment centres likely to continue in future and what benefits or disadvantages will this bring to patients? (2:35)
Sergio Sandrucci has no conflicts of interest to declare in relation to this video.
Filmed in partnership with the European CanCer Organisation at the ECCO 2019 European Cancer Summit in Brussels, Belgium.
Share this Video
Related Videos In Policy
Stefan Gijssels, Eureopean Cancer Summit 2020 – The Beating Cancer Plan
touchONCOLOGY means Stefan Gijssels at the European Cancer Summit 2020 to discuss the Beating Cancer Plan and key highlights and outcomes from this year’s meeting. Questions How do you expect the cancer burden in Europe to change in the coming years? What are the aims and main components of the Beating Cancer Plan? What initiatives […]
Françoise Meunier, European Cancer Summit 2020 – Financial Toxicity and the ‘Right to be Forgotten’
Dr Françoise Meunier, Vice President of the Federation of European Academies of Medicine, joins touchONCOLOGY to discuss financial toxicity in patients with cancer and progress made with the “Right to be Forgotten” resolution made at the European Cancer Summit in 2018. Questions What does the term ‘financial toxicity’ mean, and what does it mean for […]
Daniel Kelly, European Cancer Summit 2020 – HPV Action Network
touchONCOLOGY joins Prof. Daniel Kelly to discuss the aims and scope of the European Cancer Organisation HPV Action Network. Questions What are the aims of the HPV Action Network? How can HPV-associated cancers be reduced and why is this resolution important? Could you tell us about the European Cancer Organisation’s recent action plan and report, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!